Nova Patents
IS6922A

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Abstract

The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Method of preparing the compounds also are disclosed.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

95 members in 31 offices

This recordMember, by publication datePriority claim21 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
26984701United States of AmericaP
26984701United States of AmericaP
0204689United States of AmericaW
0204689United States of AmericaW
PCTUS0204689–––
US20010269847P–––
WO2002US04689–––

Members95

Family members, oldest first
DocumentOfficeKind
CA2381975A1CanadaA1
WO0112627A1World Intellectual Property Organization (WIPO)A1
AU6782400AAustraliaA
IS6275AIcelandA
NO20020823D0NorwayD0
NO20020823LNorwayL
KR20020038731ARepublic of KoreaA
EP1210344A1European Patent Office (EPO)A1
CZ2002599A3CzechiaA3
SK2512002A3SlovakiaA3
BR0013427ABrazilA
CA2438991A1CanadaA1
WO02068417A2World Intellectual Property Organization (WIPO)A2
IL148157A0IsraelA0
IL148157D0IsraelD0
CN1379775AChinaA
WO02068417A3World Intellectual Property Organization (WIPO)A3
HU0202757A2HungaryA2
HUP0202757A2HungaryA2
BG106493ABulgariaA
JP2003507378AJapanA
HK1047929AHong Kong, ChinaA
HK1047929A1Hong Kong, ChinaA1
US2003055085A1United States of AmericaA1
EE200200079AEstoniaA
ZA200201358BSouth AfricaB
IS6922AThis recordIcelandA
NO20033711D0NorwayD0
NO20033711LNorwayL
KR20030088434ARepublic of KoreaA
PL353825A1PolandA1
US6660753B2United States of AmericaB2
EP1379525A2European Patent Office (EPO)A2
NZ517221ANew ZealandA
MXPA02001764AMexicoA
IL157491A0IsraelA0
IL157491D0IsraelD0
MXPA03007513AMexicoA
HK1060559A1Hong Kong, ChinaA1
BR0207390ABrazilA
ZA200306493BSouth AfricaB
JP2004536037AJapanA
AU780191B2AustraliaB2
RU2003128535ARussian FederationA
PL369598A1PolandA1
US2005154027A1United States of AmericaA1
CN1649865AChinaA
EP1582519A2European Patent Office (EPO)A2
EP1210344B1European Patent Office (EPO)B1
AT307129TAustriaT
ATE307129T1AustriaT1
UA74419C2UkraineC2
EP1582519A3European Patent Office (EPO)A3
DE60023318D1GermanyD1
DK1210344T3DenmarkT3
HU0202757A3HungaryA3
HUP0202757A3HungaryA3
ES2250177T3SpainT3
JP2006143746AJapanA
UA75871C2UkraineC2
JP3790472B2JapanB2
EP1679313A2European Patent Office (EPO)A2
JP2006182789AJapanA
DE60023318T2GermanyT2
EP1679313A3European Patent Office (EPO)A3
US2006189661A1United States of AmericaA1
US7112595B2United States of AmericaB2
NO322460B1NorwayB1
CN1853630AChinaA
NZ527691ANew ZealandA
RU2296127C2Russian FederationC2
CN1313465CChinaC
IL148157AIsraelA
CN1332959CChinaC
RU2296127C9Russian FederationC9
AU2002306517B2AustraliaB2
EP1379525B1European Patent Office (EPO)B1
AT375340TAustriaT
ATE375340T1AustriaT1
DE60222872D1GermanyD1
PT1379525EPortugalE
DK1379525T3DenmarkT3
SI1379525T1SloveniaT1
ES2292830T3SpainT3
RU2319701C2Russian FederationC2
KR100838447B1Republic of KoreaB1
DE60222872T2GermanyT2
NO326105B1NorwayB1
KR100875222B1Republic of KoreaB1
BG65586B1BulgariaB1
IS2564BIcelandB
CY1105253T1CyprusT1
JP4519404B2JapanB2
CA2438991CCanadaC
CY1107005T1CyprusT1